Quotient

Quotient Enterprise Value

Delisted

The Enterprise Value (EV) of Quotient (QTNT) as of Nov 9, 2026 is 217.21 M USD. In the previous year, Enterprise Value (EV) was 108.44 M USD — a change of 100.31% (higher).

Enterprise Value

217.21 MUSD

YoY

100.31%

Last updated:

Enterprise Value (EV) of Quotient is 2022 217.21 M USD. Enterprise Value (EV) of Quotient was 2021 108.44 M USD. It decreases by 100.31% higher compared to the previous year.

The Quotient Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2015
21.10 M USD
Jan 1, 2016
31.43 M USD
Jan 1, 2017
107.27 M USD
Jan 1, 2018
108.06 M USD
Jan 1, 2019
76.30 M USD
Jan 1, 2020
85.73 M USD
Jan 1, 2021
108.44 M USD
Jan 1, 2022
217.21 M USD
The Quotient Enterprise Value history
YEAREnterprise ValueYoY
217.21 MUSD+100.31%
108.44 MUSD+26.48%
85.73 MUSD+12.36%
76.30 MUSD-29.39%
108.06 MUSD+0.74%
107.27 MUSD+241.31%
31.43 MUSD+48.93%
21.10 MUSD-42.71%
36.84 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quotient Stock analysis

What does Quotient do? Quotient Ltd is a biopharmaceutical company headquartered in Eysins, Switzerland. The company was founded in 2007 with the aim of developing innovative technologies in the field of Personalized Medicine. This means that medications and therapies are specifically tailored to the individual needs of patients. Thanks to state-of-the-art production processes, products can be produced quickly and safely. Quotient Ltd has a unique business model based on transfusion technology. This technology allows the company to produce medications quickly and accurately. The different components of the medications are separated and then combined in the required dosage. This means that the medications can be precisely dosed and the risks of side effects minimized. A key focus of Quotient Ltd is the development of therapeutics. Personalized medicine and the fast and safe production of medications are at the center of this area. The transfusion technology enables medications to be produced quickly and flexibly, which is particularly important for rare diseases and personalized therapies. Another important area is the development of diagnostics. These enable diseases to be diagnosed quickly and safely. Based on this diagnosis, suitable therapies are then developed. Quotient Ltd also relies on transfusion technology for this, which enables fast, reliable, and flexible production of diagnostics. In addition to its developed technology and know-how, Quotient Ltd also has its own production facility. Here, all products are produced to the highest standards. The production facility covers an area of approximately 6,000 square meters. The modern facility is equipped with the latest technologies and meets the highest quality standards. Quotient Ltd offers a variety of products, with a special focus on personalized medicine and the fast and safe production of medications and diagnostics. One example is the PDA diagnostic system, which was developed for the fast and accurate diagnosis of autoimmune diseases. The MosaiQ system is another important product that enables fast and reliable production of medications. The success story of Quotient Ltd is closely linked to the development of transfusion technology. The company has succeeded in developing a technology that allows for the fast and safe production of personalized medicine. This technology has made Quotient Ltd a leading company in the field of personalized medicine worldwide. Today, Quotient Ltd employs over 700 people who are constantly working on the further development of personalized medicine and transfusion technology. Quotient is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Quotient stock

Enterprise Value (EV) of Quotient is 217.21 M USD in 2022.

Enterprise Value (EV) of Quotient changed from 108.44 M USD to 217.21 M USD, representing a 100.31% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Quotient since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s USD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' USD varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Quotient with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Quotient

All Key Metrics — Quotient